Clinical trials recruiting in Mason, Ohio

Phase breakdown

Conditions recruiting in Mason, Ohio

Recruiting trials in Mason, Ohio

• A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis
  NCT07003425 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female)
• Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)
  NCT07379827 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)
• Hydrus® Microstent New Enrollment Post-Approval Study
  NCT04553523 · Phase: Not applicable (e.g. observational or device study) · Ages: 45 Years and older · Sex: All (male and female)
• Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
  NCT07116967 · Phase: Phase 3 · Ages: 40 Years and older · Sex: All (male and female)
• Modulating Spinal Interoceptive Pathways to Evaluate Their Role and Therapeutic Potential in MDD Symptomatic Domains
  NCT06795451 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 60 Years · Sex: All (male and female)
• NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
  NCT06911112 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
  NCT07290803 · Phase: Not specified · Ages: 12 Years and older · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Mason, Ohio?

7 recruiting trials have at least one study site in Mason, Ohio.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.